ZEB2 may contribute to tumor progression by protecting cancer cells from apoptosis and DNA damage by activating NF-κB, which can prevent cell death in glioma [34] and result in downregulation of E-cadherin mediated classical EMT [35]. This evidence concerns the gene ZEB2 and central nervous system cancer.